Antilymphoblast globulin in renal transplant patients. No allergic reactions
W. J. Martin 2nd, M. Blumenthal, B. Roitman, R. Condie, R. Simmons and J. Najarian
The incidence and type of allergic reactions to antilymphoblast globulin
(ALG) and their relationship to skin testing, histamine release, and serum
levels of ALG and anti-ALG antibodies were studied prospectively in 50
patients receiving high-dose ALG therapy intravenously for the first two
weeks after renal transplantation. No clinically apparent allergic
reactions occurred in the patients studied.